37481-39-3 Usage
Molecular structure
2,6-Dimethoxy-N-(1,2,3,4-tetrahydro-2-methylisoquinolin-5-yl)benzamide has a complex molecular structure that includes two methoxy groups, a tetrahydro-2-methylisoquinolin-5-yl group, and a benzamide group.
Applications in medicinal chemistry and pharmaceutical research
Due to its potential for biological activity, 2,6-Dimethoxy-N-(1,2,3,4-tetrahydro-2-methylisoquinolin-5-yl)benzamide is often used in the field of medicinal chemistry and pharmaceutical research.
Use in drug development
2,6-Dimethoxy-N-(1,2,3,4-tetrahydro-2-methylisoquinolin-5-yl)benzamide may have applications in the development of new drugs.
Use as a research tool
2,6-Dimethoxy-N-(1,2,3,4-tetrahydro-2-methylisoquinolin-5-yl)benzamide can be used as a research tool in the study of biochemical pathways and receptor interactions.
Unique composition
The compound's unique composition, including its complex molecular structure and potential for biological activity, make it an interesting and important molecule for scientific study.
Potential for further research
The potential for biological activity and applications in drug development and scientific study make 2,6-Dimethoxy-N-(1,2,3,4-tetrahydro-2-methylisoquinolin-5-yl)benzamide an important compound for further research.
Check Digit Verification of cas no
The CAS Registry Mumber 37481-39-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,7,4,8 and 1 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 37481-39:
(7*3)+(6*7)+(5*4)+(4*8)+(3*1)+(2*3)+(1*9)=133
133 % 10 = 3
So 37481-39-3 is a valid CAS Registry Number.
InChI:InChI=1/C19H22N2O3/c1-21-11-10-14-13(12-21)6-4-7-15(14)20-19(22)18-16(23-2)8-5-9-17(18)24-3/h4-9H,10-12H2,1-3H3,(H,20,22)
37481-39-3Relevant academic research and scientific papers
Compositions containing 1,2,3,4-tetrahydroisoquinolines used as hypotensive agents
-
, (2008/06/13)
Disclosed are 5,6,7 or 8-nuclear substituted benzamido-1,2,3,4-tetrahydroisoquinolines of the formula STR1 in which R is a phenyl containing one to three hydroxyl, nitro, halo, lower alkyl or lower alkoxy groups, and R1 is hydrogen or a lower alkyl. The compounds lower blood pressure in animals.